August 1, 2024

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

by

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Please follow and like us:

You may also like

Exit mobile version